Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(42.86%)
USD 0.0
(42.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -572.84 Million USD | -30.38% |
| 2021 | -429.01 Million USD | -39.03% |
| 2020 | -308.56 Million USD | 14.07% |
| 2019 | -359.1 Million USD | -76.43% |
| 2018 | -203.54 Million USD | -2346.33% |
| 2017 | 9.06 Million USD | 114.87% |
| 2016 | -60.92 Million USD | -32.99% |
| 2015 | -45.81 Million USD | -32.18% |
| 2014 | -34.65 Million USD | -58.17% |
| 2013 | -21.91 Million USD | -352.22% |
| 2012 | -4.84 Million USD | -49.71% |
| 2011 | -3.23 Million USD | -78.97% |
| 2010 | -1.8 Million USD | -91.92% |
| 2009 | -942.26 Thousand USD | -398.81% |
| 2008 | -188.9 Thousand USD | 30.2% |
| 2007 | -270.62 Thousand USD | 38.4% |
| 2006 | -439.28 Thousand USD | -42.61% |
| 2005 | -308.03 Thousand USD | -40271.04% |
| 2004 | -763.00 USD | 0.0% |
| 2003 | -763.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -139.61 Million USD | 33.1% |
| 2023 Q2 | -95.21 Million USD | 31.8% |
| 2022 Q4 | -208.68 Million USD | -130.12% |
| 2022 Q3 | -90.68 Million USD | 58.69% |
| 2022 FY | -559.33 Million USD | -30.38% |
| 2022 Q2 | -219.54 Million USD | -437.91% |
| 2022 Q1 | -40.81 Million USD | 71.74% |
| 2021 Q1 | 2.51 Million USD | 103.51% |
| 2021 Q2 | -166.61 Million USD | -6738.05% |
| 2021 Q3 | -119.8 Million USD | 28.1% |
| 2021 Q4 | -144.41 Million USD | -20.55% |
| 2021 FY | -429.01 Million USD | -39.03% |
| 2020 Q3 | -84.02 Million USD | -8.08% |
| 2020 FY | -308.56 Million USD | 14.07% |
| 2020 Q2 | -77.74 Million USD | -19.24% |
| 2020 Q1 | -65.19 Million USD | -3.78% |
| 2020 Q4 | -71.5 Million USD | 14.9% |
| 2019 Q2 | -56.76 Million USD | 47.48% |
| 2019 Q4 | -62.82 Million USD | 2.48% |
| 2019 FY | -359.1 Million USD | -76.43% |
| 2019 Q1 | -108.07 Million USD | -117.11% |
| 2019 Q3 | -64.41 Million USD | -13.48% |
| 2018 Q2 | -73.86 Million USD | -126.76% |
| 2018 Q4 | -49.77 Million USD | -5.17% |
| 2018 FY | -203.54 Million USD | -2346.33% |
| 2018 Q1 | -32.57 Million USD | -362.16% |
| 2018 Q3 | -47.32 Million USD | 35.93% |
| 2017 Q3 | 33.95 Million USD | 339.37% |
| 2017 Q1 | -23.06 Million USD | -92.89% |
| 2017 FY | 9.06 Million USD | 114.87% |
| 2017 Q4 | 12.42 Million USD | -63.41% |
| 2017 Q2 | -14.18 Million USD | 38.49% |
| 2016 FY | -60.92 Million USD | -32.99% |
| 2016 Q2 | -44.94 Million USD | -144.42% |
| 2016 Q1 | -18.39 Million USD | 21.66% |
| 2016 Q3 | 14.37 Million USD | 131.98% |
| 2016 Q4 | -11.95 Million USD | -183.19% |
| 2015 Q2 | -10.95 Million USD | -4.98% |
| 2015 FY | -45.81 Million USD | -32.18% |
| 2015 Q3 | -939 Thousand USD | 91.43% |
| 2015 Q4 | -23.47 Million USD | -2400.11% |
| 2015 Q1 | -10.43 Million USD | -22.73% |
| 2014 Q1 | -10.09 Million USD | 10.65% |
| 2014 FY | -34.65 Million USD | -58.17% |
| 2014 Q3 | -7.6 Million USD | 10.04% |
| 2014 Q2 | -8.45 Million USD | 16.24% |
| 2014 Q4 | -8.5 Million USD | -11.83% |
| 2013 Q3 | -3.35 Million USD | 29.14% |
| 2013 FY | -21.91 Million USD | -352.22% |
| 2013 Q1 | -2.52 Million USD | -43.74% |
| 2013 Q4 | -11.29 Million USD | -236.54% |
| 2013 Q2 | -4.73 Million USD | -87.79% |
| 2012 Q3 | -1.24 Million USD | -31.61% |
| 2012 FY | -4.84 Million USD | -49.71% |
| 2012 Q2 | -943.11 Thousand USD | -4.08% |
| 2012 Q1 | -906.12 Thousand USD | -18.89% |
| 2012 Q4 | -1.75 Million USD | -41.38% |
| 2011 Q1 | -684.44 Thousand USD | -263.92% |
| 2011 Q3 | -702.28 Thousand USD | 35.43% |
| 2011 FY | -3.23 Million USD | -78.97% |
| 2011 Q2 | -1.08 Million USD | -58.91% |
| 2011 Q4 | -762.12 Thousand USD | -8.52% |
| 2010 Q4 | -188.07 Thousand USD | 57.72% |
| 2010 Q1 | -599.89 Thousand USD | 12.54% |
| 2010 Q2 | -575.58 Thousand USD | 4.05% |
| 2010 Q3 | -444.83 Thousand USD | 22.72% |
| 2010 FY | -1.8 Million USD | -91.92% |
| 2009 Q3 | -231.92 Thousand USD | -191.54% |
| 2009 Q1 | -58.46 Thousand USD | -29.59% |
| 2009 FY | -942.26 Thousand USD | -398.81% |
| 2009 Q4 | -685.94 Thousand USD | -195.75% |
| 2009 Q2 | -79.55 Thousand USD | -36.07% |
| 2008 Q3 | -125.19 Thousand USD | -2203.86% |
| 2008 Q4 | -45.11 Thousand USD | 63.96% |
| 2008 Q2 | -5434.00 USD | 58.71% |
| 2008 Q1 | -13.16 Thousand USD | -77.41% |
| 2008 FY | -188.9 Thousand USD | 30.2% |
| 2007 Q3 | -10.64 Thousand USD | 15.69% |
| 2007 Q1 | -239.94 Thousand USD | 0.0% |
| 2007 FY | -270.62 Thousand USD | 38.4% |
| 2007 Q4 | -7418.00 USD | 30.28% |
| 2007 Q2 | -12.62 Thousand USD | 94.74% |
| 2006 FY | -439.28 Thousand USD | -42.61% |
| 2006 Q1 | - USD | 100.0% |
| 2005 Q3 | -191.00 USD | 0.0% |
| 2005 Q1 | -191.00 USD | -0.53% |
| 2005 FY | -308.03 Thousand USD | -40271.04% |
| 2005 Q4 | -307.45 Thousand USD | -160872.77% |
| 2005 Q2 | -191.00 USD | 0.0% |
| 2004 FY | -763.00 USD | 0.0% |
| 2004 Q2 | -191.00 USD | 0.0% |
| 2004 Q1 | -191.00 USD | 0.0% |
| 2004 Q3 | -191.00 USD | 0.0% |
| 2004 Q4 | -190.00 USD | 0.52% |
| 2003 FY | -763.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1003.212% |
| Jaguar Health, Inc. | -41.3 Million USD | -1287.029% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -274.427% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -952.595% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -30.12% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1198.368% |
| ContextLogic Inc. | -317 Million USD | -80.708% |
| MiMedx Group, Inc. | 67.43 Million USD | 949.424% |
| MEI Pharma, Inc. | 17.77 Million USD | 3322.202% |
| AlloVir, Inc. | -190.41 Million USD | -200.834% |
| Novavax, Inc. | -545.06 Million USD | -5.097% |
| Aptorum Group Limited | -2.82 Million USD | -20180.162% |
| Ardelyx, Inc. | -66.06 Million USD | -767.064% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -179.061% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1019.73% |
| Vaxcyte, Inc. | -402.26 Million USD | -42.404% |
| Precigen, Inc. | -95.9 Million USD | -497.309% |
| Pharming Group N.V. | -10.54 Million USD | -5330.821% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -184.16% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2234.038% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2183.062% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -169.929% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2988.753% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2253.573% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2253.573% |
| Bicycle Therapeutics plc | -180.66 Million USD | -217.076% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -122.178% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2003.102% |
| Acelyrin, Inc. | -381.64 Million USD | -50.1% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1434.127% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1579.842% |
| Senti Biosciences, Inc. | -92.91 Million USD | -516.497% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -447.133% |
| AbCellera Biologics Inc. | -146.39 Million USD | -291.292% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1530.174% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -219.929% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -8469.08% |
| Chimerix, Inc. | -82.09 Million USD | -597.781% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1850.967% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2723.138% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1184.306% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1021.946% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1153.376% |
| Alkermes plc | 355.75 Million USD | 261.021% |
| Fortress Biotech, Inc. | -60.63 Million USD | -844.709% |
| Fortress Biotech, Inc. | -60.63 Million USD | -844.709% |
| Agenus Inc. | -245.76 Million USD | -133.089% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -602.186% |
| Dyadic International, Inc. | -6.79 Million USD | -8329.789% |
| ImmuCell Corporation | -5.77 Million USD | -9820.05% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -61101.175% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -407.116% |
| Lantern Pharma Inc. | -15.96 Million USD | -3488.897% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3613.479% |
| Incyte Corporation | 597.59 Million USD | 195.857% |
| IO Biotech, Inc. | -86.08 Million USD | -565.454% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -882.696% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2910.387% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -871.206% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -248.076% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6638.537% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -681.004% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -53.318% |
| NextCure, Inc. | -62.72 Million USD | -813.29% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5636.461% |
| Onconetix, Inc. | -37.4 Million USD | -1431.269% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1351.007% |
| Opthea Limited | -220.24 Million USD | -160.097% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1233.986% |
| PureTech Health plc | -65.69 Million USD | -771.947% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -676.315% |
| Seer, Inc. | -86.27 Million USD | -563.958% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4567046.282% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1663.408% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4282.259% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1913.366% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -896.024% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -820.156% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -332.357% |
| ChromaDex Corporation | -4.93 Million USD | -11500.709% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -15865.524% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -461.226% |
| CRISPR Therapeutics AG | -153.61 Million USD | -272.92% |
| Precision BioSciences, Inc. | -61.31 Million USD | -834.201% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -255.962% |
| Innoviva, Inc. | 179.72 Million USD | 418.738% |
| Summit Therapeutics Inc. | -614.92 Million USD | 6.844% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -755.053% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -771.045% |
| ESSA Pharma Inc. | -26.58 Million USD | -2054.976% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1452.444% |
| GT Biopharma, Inc. | -7.59 Million USD | -7440.384% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -137.339% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 902.189% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1066.211% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5658.521% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -133.247% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1018.681% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -482.762% |
| Soligenix, Inc. | -6.14 Million USD | -9228.581% |
| Century Therapeutics, Inc. | -136.67 Million USD | -319.134% |
| Kura Oncology, Inc. | -152.63 Million USD | -275.312% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -542.071% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5335.975% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 101403.871% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -100575.395% |
| Autolus Therapeutics plc | -208.38 Million USD | -174.899% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -696.744% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -709.157% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2543.728% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -154.314% |
| GRI Bio, Inc. | -13.03 Million USD | -4293.979% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -13754.933% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -361.657% |
| IGM Biosciences, Inc. | -246.41 Million USD | -132.47% |
| INmune Bio, Inc. | -30 Million USD | -1808.968% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -418.133% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1257.648% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3488.869% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3526.74% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -859.777% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -466.235% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -107.457% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -140.8% |
| Verastem, Inc. | -87.36 Million USD | -555.674% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -957.14% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -255.062% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -391.045% |
| Histogen Inc. | -10.62 Million USD | -5293.494% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3909.609% |
| Surrozen, Inc. | -43.04 Million USD | -1230.893% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3804.594% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11160.856% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -994.487% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2167.518% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2026.524% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6754.578% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -279.153% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1070.835% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1827.142% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5398.745% |
| Apollomics, Inc. | -172.6 Million USD | -231.889% |
| Amarin Corporation plc | -59.11 Million USD | -869.081% |
| Mesoblast Limited | -87.95 Million USD | -551.284% |
| Turnstone Biologics Corp. | -55.2 Million USD | -937.759% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -289.79% |
| Synaptogenix, Inc. | -6.03 Million USD | -9386.505% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3434.323% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -634.226% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11855.485% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6717.777% |
| Exelixis, Inc. | 207.76 Million USD | 375.717% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1340.752% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -297.951% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -8.364% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4606.224% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7249.144% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1762.965% |
| Gritstone bio, Inc. | -138.49 Million USD | -313.635% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -788.611% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -14221.254% |
| Avid Bioservices, Inc. | -140.75 Million USD | -306.985% |
| Insmed Incorporated | -749.56 Million USD | 23.577% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3671.307% |
| MediWound Ltd. | -6.71 Million USD | -8429.527% |
| OmniAb, Inc. | -50.61 Million USD | -1031.676% |
| Alector, Inc. | -130.39 Million USD | -339.327% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -403.713% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1004.872% |
| Zai Lab Limited | -334.62 Million USD | -71.192% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -76.811% |
| Aura Biosciences, Inc. | -76.4 Million USD | -649.716% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -144.145% |
| Immunic, Inc. | -93.61 Million USD | -511.933% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -321.54% |
| Veracyte, Inc. | -74.4 Million USD | -669.909% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7363.218% |
| FibroGen, Inc. | -284.23 Million USD | -101.541% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2083.756% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8081.262% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2941.748% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 238.09% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2439.761% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1262.637% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4620.541% |
| Galecto, Inc. | -38.34 Million USD | -1393.763% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2936.378% |
| Fortrea Holdings Inc. | -3.4 Million USD | -16748.324% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -352.325% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3190.121% |
| XBiotech Inc. | -24.55 Million USD | -2232.708% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -788.611% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -813.917% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -482.004% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2573.463% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -937.891% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 5.571% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -739.269% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1006052.738% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -152.867% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2472.55% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -160.727% |
| NexImmune, Inc. | -32.34 Million USD | -1671.074% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -10735.808% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3978.366% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 114.489% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2265.068% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4834.122% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -390.456% |
| Ainos, Inc. | -13.77 Million USD | -4059.914% |
| Pluri Inc. | -20.88 Million USD | -2642.45% |
| Prothena Corporation plc | -147.02 Million USD | -289.615% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -403.063% |
| Celularity Inc. | -196.29 Million USD | -191.828% |
| Rallybio Corporation | -74.56 Million USD | -668.257% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1029.133% |
| MeiraGTx Holdings plc | -84.02 Million USD | -581.737% |
| Omeros Corporation | -117.81 Million USD | -386.231% |
| Humacyte, Inc. | -110.77 Million USD | -417.118% |
| Immunocore Holdings plc | -55.28 Million USD | -936.126% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3085.292% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2398.116% |
| Blueprint Medicines Corporation | -506.98 Million USD | -12.99% |
| CalciMedica, Inc. | -34.35 Million USD | -1567.325% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -746.462% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -305.108% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -245.525% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -102.236% |
| Pulmatrix, Inc. | -14.12 Million USD | -3956.674% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1527.626% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -593.196% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -19.047% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -446.236% |
| Cytokinetics, Incorporated | -526.24 Million USD | -8.855% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1488.363% |
| Nutriband Inc. | -5.48 Million USD | -10343.213% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1317.227% |
| Vor Biopharma Inc. | -117.86 Million USD | -386.024% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 113.172% |
| Evogene Ltd. | -23.87 Million USD | -2298.94% |
| ProKidney Corp. | -35.46 Million USD | -1515.098% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -378.314% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7201.651% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 10.939% |
| CorMedix Inc. | -46.33 Million USD | -1136.195% |
| BioLineRx Ltd. | -60.61 Million USD | -845.067% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -463.024% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1294.933% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1324.132% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -610.281% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -658.521% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -96.051% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1954.968% |
| MediciNova, Inc. | -8.57 Million USD | -6583.1% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -364.68% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6738.419% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2106.063% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -139.445% |
| Biomea Fusion, Inc. | -117.25 Million USD | -388.545% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 8.58% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1844.081% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -274.011% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -173.616% |
| Absci Corporation | -110.56 Million USD | -418.101% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1799.977% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -468.088% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -142.795% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4167.332% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -196.868% |
| Allakos Inc. | -185.7 Million USD | -208.476% |
| Imunon, Inc. | -19.51 Million USD | -2835.402% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -488.527% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 639.705% |
| BioAtla, Inc. | -123.46 Million USD | -363.983% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4606.224% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3462.9% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -75.039% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1450.361% |
| XOMA Corporation | -40.83 Million USD | -1302.961% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -462.327% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -383.359% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1036.841% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -553.341% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -277.469% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -140.96% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1531.148% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6979.18% |
| Akari Therapeutics, Plc | -10 Million USD | -5623.851% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -850762.235% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 303.429% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8494.924% |
| UroGen Pharma Ltd. | -102.24 Million USD | -460.271% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -436.405% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7265.687% |
| Orgenesis Inc. | -55.36 Million USD | -934.741% |
| Entera Bio Ltd. | -8.88 Million USD | -6344.403% |
| GH Research PLC | -35.58 Million USD | -1509.697% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2648.767% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -640.222% |
| Xencor, Inc. | -126.08 Million USD | -354.324% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -15112.117% |
| Replimune Group, Inc. | -215.79 Million USD | -165.458% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2593.636% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 22931.527% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -8494.924% |
| Portage Biotech Inc. | -75.33 Million USD | -660.354% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6738.419% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -492.668% |
| OncoCyte Corporation | -27.78 Million USD | -1961.996% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4169.464% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5050.762% |
| Purple Biotech Ltd. | -19.88 Million USD | -2781.504% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8061.319% |
| scPharmaceuticals Inc. | -54.81 Million USD | -945.143% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3172.24% |
| HilleVax, Inc. | -123.56 Million USD | -363.593% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5567.785% |
| Tharimmune, Inc. | -9.31 Million USD | -6046.982% |
| Genprex, Inc. | -30.86 Million USD | -1756.236% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -142.807% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1803.512% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -32046.072% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -10716.491% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3404520.141% |
| Savara Inc. | -54.69 Million USD | -947.283% |
| Curis, Inc. | -47.41 Million USD | -1108.198% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1799.259% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3608.901% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -10186.281% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1821.325% |
| BeiGene, Ltd. | -881.7 Million USD | 35.03% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2590.162% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -31.276% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -625.531% |
| Erasca, Inc. | -125.04 Million USD | -358.12% |
| bluebird bio, Inc. | -211.91 Million USD | -170.32% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -11355.721% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 441.7% |
| DBV Technologies S.A. | -72.72 Million USD | -687.673% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -11355.721% |
| Moderna, Inc. | -4.71 Billion USD | 87.848% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1326.508% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9960.467% |
| Molecular Templates, Inc. | -8.12 Million USD | -6951.243% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -848.604% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -414.226% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -323.225% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1095.44% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -305.039% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -197.72% |
| MacroGenics, Inc. | -9.05 Million USD | -6224.166% |
| RenovoRx, Inc. | -10.23 Million USD | -5498.544% |
| Adicet Bio, Inc. | -142.65 Million USD | -301.55% |
| Prime Medicine, Inc. | -198.13 Million USD | -189.12% |
| Aditxt, Inc. | -32.38 Million USD | -1669.08% |
| Adagene Inc. | -18.94 Million USD | -2923.497% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7734.583% |
| Quantum-Si incorporated | -95.96 Million USD | -496.96% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -381.263% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3829.566% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 532.89% |
| SciSparc Ltd. | -5.12 Million USD | -11083.971% |
| Vericel Corporation | -3.18 Million USD | -17902.608% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -476260.869% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1809.136% |
| Generation Bio Co. | -126.61 Million USD | -352.44% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -685.89% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -594.844% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -118.526% |
| Invivyd, Inc. | -198.64 Million USD | -188.378% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -67.511% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6494.58% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2611.808% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5701.529% |
| 2seventy bio, Inc. | -217.57 Million USD | -163.291% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1928.553% |
| Clene Inc. | -49.5 Million USD | -1057.165% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2470.239% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1058.804% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2106.063% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -74.612% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1660.27% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2621.316% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -479.849% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -666.304% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -256.235% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 6.864% |
| Evaxion Biotech A/S | -22.12 Million USD | -2489.121% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -609.526% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -186.324% |
| Trevena, Inc. | -40.28 Million USD | -1321.835% |
| Surrozen, Inc. | -43.04 Million USD | -1230.893% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -728.598% |
| Cingulate Inc. | -23.53 Million USD | -2334.01% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8187.659% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1337.137% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -7329.222% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -535.011% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -834.705% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -862.713% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4691.648% |
| Kronos Bio, Inc. | -112.67 Million USD | -408.412% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -727.844% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -22586297.921% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -566.911% |
| Statera Biopharma, Inc. | -174.4 Million USD | -228.45% |
| ImmunityBio, Inc. | -583.19 Million USD | 1.775% |
| Korro Bio, Inc. | -81.17 Million USD | -605.715% |
| Kineta, Inc. | -14.09 Million USD | -3963.004% |
| BioVie Inc. | -32.12 Million USD | -1683.417% |
| Codexis, Inc. | -76.24 Million USD | -651.368% |
| Celularity Inc. | -196.29 Million USD | -191.828% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -167.024% |
| Celcuity Inc. | -63.77 Million USD | -798.167% |
| Virax Biolabs Group Limited | -6.73 Million USD | -8407.312% |
| Cibus, Inc. | -267.62 Million USD | -114.045% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1320.53% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1499.629% |
| IN8bio, Inc. | -30 Million USD | -1809.031% |
| Kodiak Sciences Inc. | -260.49 Million USD | -119.909% |
| Annexon, Inc. | -134.23 Million USD | -326.74% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -388.92% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -835.59% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1716.013% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -56.392% |
| Eyenovia, Inc. | -27.26 Million USD | -2001.321% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2753.156% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -106973.458% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -649.755% |
| Arcellx, Inc. | -70.69 Million USD | -710.359% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1282.31% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -328.083% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1807.125% |
| Moolec Science SA | -51.78 Million USD | -1006.112% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -993.817% |
| Geron Corporation | -184.12 Million USD | -211.113% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1264.757% |
| Royalty Pharma plc | 1.13 Billion USD | 150.478% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -321.344% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6342.372% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2596.591% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -233.688% |
| Humacyte, Inc. | -110.77 Million USD | -417.118% |
| Structure Therapeutics Inc. | -89.62 Million USD | -539.191% |
| 89bio, Inc. | -142.18 Million USD | -302.874% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -730.689% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5420.314% |
| Genelux Corporation | -28.29 Million USD | -1924.395% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1870.903% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -223.423% |
| Notable Labs, Ltd. | -11.26 Million USD | -4985.609% |
| Liquidia Corporation | -78.5 Million USD | -629.718% |
| Mustang Bio, Inc. | -51.6 Million USD | -1010.118% |
| Immunovant, Inc. | -259.33 Million USD | -120.888% |
| Quantum-Si incorporated | -95.96 Million USD | -496.96% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -686.343% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2855.694% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -496.774% |
| Acasti Pharma Inc. | -12.85 Million USD | -4356.882% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2450.746% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3488.869% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -214.071% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -13217.232% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4493.769% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1842.433% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1369.28% |
| PepGen Inc. | -78.62 Million USD | -628.567% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1824.294% |
| United Therapeutics Corporation | 984.8 Million USD | 158.168% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2473.419% |
| Solid Biosciences Inc. | -96.01 Million USD | -496.618% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11855.485% |
| Immuneering Corporation | -53.47 Million USD | -971.303% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11160.856% |
| Silo Pharma, Inc. | -3.7 Million USD | -15379.386% |
| Belite Bio, Inc | -31.63 Million USD | -1710.96% |
| XOMA Corporation | -40.83 Million USD | -1302.961% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -953.698% |
| Bionomics Limited | -15.49 Billion USD | 96.302% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -582.078% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1864.684% |
| uniQure N.V. | -308.47 Million USD | -85.7% |
| Cassava Sciences, Inc. | -97.21 Million USD | -489.242% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7734.583% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -364.104% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1719.936% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6884.44% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1870.7% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -106973.458% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2083.756% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3374.935% |
| Altimmune, Inc. | -88.44 Million USD | -547.668% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -277.905% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1864.684% |
| Compugen Ltd. | -18.75 Million USD | -2954.511% |
| Peak Bio, Inc. | -1259.26 USD | -45490346.77% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1143.986% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2533.64% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -69.085% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -590.555% |
| Zura Bio Limited | -60.36 Million USD | -849.044% |
| PolyPid Ltd. | -23.86 Million USD | -2300.348% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3541.26% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -590.555% |
| Instil Bio, Inc. | -156.08 Million USD | -267.002% |
| argenx SE | -295.05 Million USD | -94.149% |
| Immunome, Inc. | -106.8 Million USD | -436.34% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1248.056% |
| Verona Pharma plc | -54.36 Million USD | -953.621% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -473.319% |
| Shattuck Labs, Inc. | -87.29 Million USD | -556.193% |
| CervoMed Inc. | -2.17 Million USD | -26275.529% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -359.557% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4201.915% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1215.218% |
| Moolec Science SA | -51.78 Million USD | -1006.112% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3312714.854% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -323.96% |
| AnaptysBio, Inc. | -163.61 Million USD | -250.108% |
| Design Therapeutics, Inc. | -66.86 Million USD | -756.754% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -603.617% |
| NeurAxis, Inc. | -14.62 Million USD | -3816.425% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1412.177% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1583.149% |
| Achilles Therapeutics plc | -69.66 Million USD | -722.282% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -473.319% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2773.538% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 19138.982% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -22586297.921% |
| Nutriband Inc. | -5.48 Million USD | -10343.213% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -468.878% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1078.52% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -643.074% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1586.32% |
| MoonLake Immunotherapeutics | -36 Million USD | -1490.91% |
| Palisade Bio, Inc. | -12.3 Million USD | -4557.26% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1259.897% |
| Beam Therapeutics Inc. | -132.52 Million USD | -332.246% |
| Neurogene Inc. | -36.31 Million USD | -1477.341% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -250.545% |
| AEON Biopharma, Inc. | -52.55 Million USD | -989.967% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -483.658% |
| Sesen Bio, Inc. | -19.88 Million USD | -2780.924% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -700.239% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4477.655% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -29.008% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -413.457% |
| Athira Pharma, Inc. | -117.67 Million USD | -386.813% |
| Vaccinex, Inc. | -20.25 Million USD | -2728.715% |
| HCW Biologics Inc. | -24.99 Million USD | -2191.897% |
| XOMA Corporation | -40.83 Million USD | -1302.961% |
| Nektar Therapeutics | -276.05 Million USD | -107.51% |
| Arvinas, Inc. | -367.3 Million USD | -55.961% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -850762.235% |
| Merus N.V. | -154.93 Million USD | -269.722% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -487.965% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1725.213% |
| Rezolute, Inc. | -68.45 Million USD | -736.768% |
| Clene Inc. | -49.5 Million USD | -1057.165% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3614.099% |
| BeyondSpring Inc. | -21.02 Million USD | -2624.451% |
| Synlogic, Inc. | -57.28 Million USD | -900.04% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4713.402% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5191.363% |
| Peak Bio, Inc. | -1259.26 USD | -45490346.77% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1432.977% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5340.057% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -300.312% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -76.203% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -12301.977% |
| MannKind Corporation | -11.93 Million USD | -4698.484% |
| Ikena Oncology, Inc. | -68.16 Million USD | -740.365% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2625.877% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -516.404% |
| Gossamer Bio, Inc. | -179.81 Million USD | -218.57% |
| CohBar, Inc. | -11.96 Million USD | -4688.809% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2121.355% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1799.977% |
| Legend Biotech Corporation | -518.25 Million USD | -10.533% |
| Mural Oncology plc | -207.44 Million USD | -176.139% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -361.542% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3032.048% |
| Disc Medicine, Inc. | -76.42 Million USD | -649.51% |
| Champions Oncology, Inc. | -7.27 Million USD | -7773.048% |
| REGENXBIO Inc. | -263.49 Million USD | -117.403% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5297.522% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1105.858% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1408.137% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -471.911% |
| Vaxart, Inc. | -82.46 Million USD | -594.65% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 171731.667% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1425.852% |
| Cellectis S.A. | -101.05 Million USD | -466.84% |
| Longeveron Inc. | -21.41 Million USD | -2575.211% |
| Repare Therapeutics Inc. | -93.79 Million USD | -510.733% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -6.878% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -704.905% |
| Revolution Medicines, Inc. | -436.36 Million USD | -31.276% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -8617.745% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1758.432% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -726.22% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -784.946% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5738.783% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 115.826% |
| Denali Therapeutics Inc. | -145.22 Million USD | -294.455% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -476260.869% |
| Veru Inc. | -93.15 Million USD | -514.951% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2019.364% |
| Cingulate Inc. | -23.53 Million USD | -2334.01% |
| Passage Bio, Inc. | -102.06 Million USD | -461.27% |
| Context Therapeutics Inc. | -23.96 Million USD | -2290.41% |
| Exicure, Inc. | -16.91 Million USD | -3286.798% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -203.225% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1416.902% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -8703.05% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -210.185% |
| Nuvalent, Inc. | -126.21 Million USD | -353.848% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5347.525% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -559.357% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1775.468% |
| OmniAb, Inc. | -50.61 Million USD | -1031.676% |
| Anew Medical, Inc. | 1.34 Million USD | 42654.963% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3470.227% |
| Lipocine Inc. | -16.35 Million USD | -3403.181% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -762.793% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -799.636% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1257.648% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1094.244% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2788.624% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -5.79% |
| Ocugen, Inc. | -63.07 Million USD | -808.15% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -498.382% |
| Q32 Bio Inc. | -112.96 Million USD | -407.116% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3232.032% |
| Alumis Inc. Common Stock | -154.99 Million USD | -269.593% |
| Equillium, Inc. | -13.33 Million USD | -4195.786% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -848.95% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7071.442% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2938.757% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -869.573% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -400.182% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3017.012% |
| Dominari Holdings Inc. | -22.88 Million USD | -2403.466% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6740.394% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2728.854% |
| Bio-Techne Corporation | 168.1 Million USD | 440.765% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -62.699% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 544.571% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -370.191% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1409.905% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -408.552% |
| Nkarta, Inc. | -117.5 Million USD | -387.522% |
| BioCardia, Inc. | -11.57 Million USD | -4850.678% |
| Iterum Therapeutics plc | -38.37 Million USD | -1392.906% |